Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Cardiol ; 331: 199-205, 2021 05 15.
Article in English | MEDLINE | ID: mdl-33421451

ABSTRACT

BACKGROUND: We previously demonstrated that high-density lipoprotein (HDL) infusions may improve left ventricular diastolic dysfunction (LVDD) in an aortic valve stenosis (AVS) model. Whether the benefit was direct or mediated by the observed reduction in AVS severity is not clear. Here, we aimed to test the direct effect of an ApoA-I mimetic on LVDD in the absence of AVS. METHODS: Rabbits were exposed to three different protocols to develop LVDD. First, rabbits were exposed to 0.5% cholesterol-rich diet for an average of 17 weeks. Second, rabbits were subjected to surgical ascending aortic constriction (AAC), to mimic the effect of fixed reduced aortic valve area, and studied after 10 weeks. The third model combined both cholesterol-enriched diet (for 12 weeks) and surgical AAC. The control group consisted of age-matched rabbits under normal diet. After development of LVDD, rabbits were randomized to receive infusions of saline or apoA-I mimetic (25 mg/kg) 3 times per week for 4 weeks. Detailed cardiac structure and function measurements were assessed at baseline and weekly during treatment period. Histological and molecular analyses were performed on LV samples. RESULTS: In the three models, echocardiographic results showed development of LVDD over time, with preserved LV systolic and aortic valve functions versus controls. ApoA-I mimetic infusions did not significantly improve echocardiographic parameters nor molecular markers of cardiac inflammation, oxidative stress and fibrosis. CONCLUSION: ApoA-I mimetic therapy did not directly improve LVDD. These results indicate that previously observed changes of LVDD were caused by AVS improvement induced by this treatment.


Subject(s)
Aortic Valve Stenosis , Ventricular Dysfunction, Left , Animals , Rabbits , Aortic Valve/diagnostic imaging , Aortic Valve Stenosis/diagnostic imaging , Aortic Valve Stenosis/drug therapy , Apolipoprotein A-I , Echocardiography , Lipoproteins, HDL , Ventricular Dysfunction, Left/drug therapy , Ventricular Function, Left
2.
PLoS One ; 14(8): e0220707, 2019.
Article in English | MEDLINE | ID: mdl-31393963

ABSTRACT

BACKGROUND: Left ventricular diastolic dysfunction (LVDD) is present in more than 50% of patients suffering from heart failure. LVDD animal models are limited and its underlying mechanisms remain largely unknown. Aortic valve stenosis (AVS) may cause LVDD, and we recently reported LVDD in an AVS rabbit model. Here we aimed to develop a rabbit model of LVDD without AVS. METHODS: Rabbits were fed with a 0.5% cholesterol-enriched diet (n = 9) or normal diet (n = 8) until they developed LVDD defined by a value of the echocardiographic parameter E/Em ratio higher than the mean at baseline + 2SD. Rabbits were then fed a 0.2% cholesterol-enriched diet for 4 weeks (average total diet duration: 20 weeks). Detailed cardiac structure and function measurements were assessed by echocardiography at baseline, weeks 8, 12 and 14 to 20, when applicable. Histological analyses and RT-qPCR were performed on LV samples. RESULTS: The hypercholesterolemic diet induced LVDD without systolic dysfunction or AVS, as shown by multiple echocardiographic parameters, including early filling mitral peak velocity and deceleration rate, Em/Am ratio and E/Em ratio (all p<0.05), and by increased cardiac mRNA expression of brain natriuretic peptide (Bnp). Cardiac expression of mRNA for Nox2, Vcam1, Mmp12, Mmp12/Timp1, Il1b and Col1/Col3 ratios was also higher in these rabbits (p<0.05). In contrast, cardiac Sod2 mRNA expression was reduced in hypercholesterolemic rabbits compared to controls. CONCLUSION: Rabbits fed with a cholesterol-enriched diet develop LVDD with preserved systolic function and evidence of cardiac inflammation and oxidative stress. This rabbit model may be used in future studies to test treatment strategies against LVDD.


Subject(s)
Hypercholesterolemia/complications , Ventricular Dysfunction, Left/etiology , Animals , Cholesterol/adverse effects , Disease Models, Animal , Echocardiography , Heart Failure, Diastolic/diagnostic imaging , Heart Failure, Diastolic/etiology , Inflammation/etiology , Oxidative Stress , Rabbits , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Dysfunction, Left/pathology
3.
Atherosclerosis ; 258: 8-19, 2017 03.
Article in English | MEDLINE | ID: mdl-28167355

ABSTRACT

BACKGROUND AND AIMS: The potential benefits of high-density lipoproteins (HDL) against atherosclerosis are attributed to its major protein component, apolipoprotein A-I (apoA-I). Most of the apoA-I in the vascular wall appears to be in its lipid-poor form. The latter, however, is subjected to degradation by proteases localized in atherosclerotic plaques, which, in turn, has been shown to negatively impact its atheroprotective functions. Here, we report the development and in vivo use of a bioactivatable near-infrared full-length apoA-I-Cy5.5 fluorescent probe for the assessment of apoA-I-degrading proteolytic activities. METHODS: Fluorescence quenching was obtained by saturation of Cy5.5 fluorophore molecules on apoA-I protein. ApoA-I cleavage led to near-infrared fluorescence enhancement. In vitro proteolysis of the apoA-I probe by a variety of proteases including serine, cysteine, and metalloproteases resulted in an up to 11-fold increase in fluorescence (n = 5, p ≤ 0.05). RESULTS: We detected activation of the probe in atherosclerotic mice aorta sections using in situ zymography and showed that broad-spectrum protease inhibitors protected the probe from degradation, resulting in decreased fluorescence (-54%, n = 6 per group, p ≤ 0.0001). In vivo, the injected probe showed stronger fluorescence emission in the aorta of human apoB transgenic Ldlr-/- atherosclerotic mice (ATX) as compared to wild-type mice. In vivo observations were confirmed by ex vivo aorta imaging quantification where a 10-fold increase in fluorescent signal in ATX mice (p ≤ 0.05 vs. control mice) was observed. CONCLUSIONS: The use of this probe in different applications may help to assess new molecular mechanisms of atherosclerosis and may improve current HDL-based therapies by enhancing apoA-I functionality.


Subject(s)
Aorta, Thoracic/enzymology , Aortic Diseases/enzymology , Apolipoprotein A-I/metabolism , Atherosclerosis/enzymology , Carbocyanines/chemistry , Fluorescent Dyes/chemistry , Molecular Imaging/methods , Peptide Hydrolases/metabolism , Animals , Aorta, Thoracic/pathology , Aortic Diseases/genetics , Aortic Diseases/pathology , Apolipoprotein A-I/chemistry , Apolipoprotein B-100/genetics , Apolipoprotein B-100/metabolism , Atherosclerosis/genetics , Atherosclerosis/pathology , Cathepsins/metabolism , Cell Line , Chymases/metabolism , Disease Models, Animal , Humans , Kinetics , Macrophages/enzymology , Matrix Metalloproteinase 12/metabolism , Mice, Inbred C57BL , Mice, Knockout , Protein Stability , Proteolysis , Receptors, LDL/deficiency , Receptors, LDL/genetics , Spectrometry, Fluorescence , Spectroscopy, Near-Infrared , Trypsin/metabolism
4.
Int J Cardiol ; 215: 364-71, 2016 Jul 15.
Article in English | MEDLINE | ID: mdl-27128563

ABSTRACT

OBJECTIVES: High-density lipoprotein (HDL) infusions induce rapid improvement of experimental atherosclerosis in rabbits but their effect on ventricular function remains unknown. We aimed to evaluate the effects of the HDL mimetic peptide CER-522 on left ventricular diastolic dysfunction (LVDD). METHODS: Rabbits were fed with a cholesterol- and vitamin D2-enriched diet until mild aortic valve stenosis and hypercholesterolemia-induced LV hypertrophy and LVDD developed. Animals then received saline or 10 or 30mg/kg CER-522 infusions 6 times over 2weeks. We performed serial echocardiograms and LV histology to evaluate the effects of CER-522 therapy on LVDD. RESULTS: LVDD was reduced by CER-522 as shown by multiple parameters including early filling mitral deceleration time, deceleration rate, Em/Am ratio, E/Em ratio, pulmonary venous velocities, and LVDD score. These findings were associated with reduced macrophages (RAM-11 positive cells) in the pericoronary area and LV, and decreased levels of apoptotic cardiomyocytes in CER-522-treated rabbits. CER-522 treatment also resulted in decreased atheromatous plaques and internal elastic lamina area in coronary arteries. CONCLUSIONS: CER-522 improves LVDD in rabbits, with reductions of LV macrophage accumulation, cardiomyocyte apoptosis, coronary atherosclerosis and remodelling.


Subject(s)
Aortic Valve Stenosis/physiopathology , Cholesterol/administration & dosage , Hypercholesterolemia/physiopathology , Hypertrophy, Left Ventricular/drug therapy , Peptidomimetics/administration & dosage , Ventricular Dysfunction, Left/drug therapy , Animals , Aortic Valve Stenosis/chemically induced , Apoptosis/drug effects , Cells, Cultured , Cholesterol/adverse effects , Disease Models, Animal , Humans , Hypercholesterolemia/chemically induced , Hypertrophy, Left Ventricular/physiopathology , Lipoproteins, HDL/chemistry , Macrophages/cytology , Macrophages/drug effects , Myocytes, Cardiac/cytology , Myocytes, Cardiac/drug effects , Peptidomimetics/pharmacology , Rabbits , Ventricular Dysfunction, Left/physiopathology
5.
Atherosclerosis ; 236(2): 277-85, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25108619

ABSTRACT

OBJECTIVE: Excessive neointima formation often occurs after arterial injury. Interleukin-1ß (IL-1ß) is a potent pleiotropic cytokine that has been shown to regulate neointimal proliferation. We investigated the effects of the IL-1ß modulator gevokizumab in a rat carotid denudation model. METHODS: Sprague-Dawley rats were subjected to balloon denudation of the right carotid artery and were then randomized to receive a single subcutaneous infusion immediately after balloon injury of saline (control group, n = 13) or gevokizumab (gevokizumab groups, n = 15 in each group: 1, 10 and 50 mg/kg). We evaluated the treatment effects on carotid intima-media thickness (IMT) using ultrasonography, on endothelial regrowth using Evans Blue staining and on inflammatory response using histology. We also assessed the effects of IL-1ß and gevokizumab on human umbilical vein endothelial cells (HUVEC) and rat smooth muscle cells. RESULTS: We found that carotid IMT, in the proximal part of the denuded artery at day 28, was decreased by gevokizumab 1 mg/kg compared with controls. Neointima area and the intima/media area ratio were both reduced in the gevokizumab 1 mg/kg-treated group. Gevokizumab at the 1 mg/kg dose also improved endothelial regrowth. No effect was observed with gevokizumab 10 or 50 mg/kg. Gevokizumab also decreased the inflammatory effect of IL-1ß in in vitro cell experiments and protected HUVECs from IL-1ß's deleterious effects on cell migration, apoptosis and proliferation. CONCLUSION: A single administration of gevokizumab 1 mg/kg improves endothelial regrowth and reduces neointima formation in rats following carotid denudation, at least in part through its beneficial effects on endothelial cells.


Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Carotid Artery Injuries/drug therapy , Neointima/prevention & control , Animals , Antibodies, Monoclonal, Humanized/administration & dosage , Antibodies, Monoclonal, Humanized/pharmacology , Aorta/cytology , Apoptosis/drug effects , Carotid Artery Injuries/diagnostic imaging , Carotid Artery Injuries/pathology , Carotid Artery, Common/diagnostic imaging , Carotid Artery, Common/pathology , Carotid Intima-Media Thickness , Cell Division/drug effects , Cell Movement/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Endothelial Cells/drug effects , Endothelial Cells/pathology , Endothelium, Vascular/physiopathology , Gene Expression Profiling , Human Umbilical Vein Endothelial Cells , Humans , Interleukin-1beta/pharmacology , Interleukin-1beta/physiology , Male , Myocytes, Smooth Muscle/drug effects , Neointima/drug therapy , Random Allocation , Rats , Rats, Sprague-Dawley , Regeneration , Vasculitis/drug therapy , Vasculitis/prevention & control
6.
PLoS One ; 9(2): e89331, 2014.
Article in English | MEDLINE | ID: mdl-24558494

ABSTRACT

Left ventricular diastolic dysfunction (LVDD) is characterized by the disturbance of ventricle's performance due to its abnormal relaxation or to its increased stiffness during the diastolic phase. The molecular mechanisms underlying LVDD remain unknown. We aimed to identify normalization genes for accurate gene-expression analysis of LVDD using quantitative real-time PCR (RT-PCR) in a new rabbit model of LVDD. Eighteen rabbits were fed with a normal diet (n = 7) or a 0.5% cholesterol-enriched diet supplemented with vitamin D2 (n = 11) for an average of 14.5 weeks. We validated the presence of LVDD in this model using echocardiography for diastolic function assessment. RT-PCR was performed using cDNA derived from left ventricle samples to measure the stability of 10 genes as candidate reference genes (Gapdh, Hprt1, Ppia, Sdha, Rpl5, Actb, Eef1e1, Ywhaz, Pgk1, and G6pd). Using geNorm analysis, we report that Sdha, Gapdh and Hprt1 genes had the highest stability (M <0.2). By contrast, Hprt1 and Rpl5 genes were found to represent the best combination for normalization when using the Normfinder algorithm (stability value of 0.042). Comparison of both normalization strategies highlighted an increase of natriuretic peptides (Bnp and Anp), monocytes chemotactic protein-1 (Mcp-1) and NADPH oxidase subunit (Nox-2) mRNA expressions in ventricle samples of the hypercholesterolemic rabbits compared to controls (P<0.05). This increase correlates with LVDD echocardiographic parameters and most importantly it molecularly validates the presence of the disease in our model. This is the first study emphasizing the selection of stable reference genes for RT-PCR normalization in a rabbit model of LVDD.


Subject(s)
Disease Models, Animal , Genetic Markers/genetics , Ventricular Dysfunction, Left/metabolism , Analysis of Variance , Animals , DNA Primers/genetics , DNA, Complementary/biosynthesis , Diet, High-Fat , Echocardiography , Gene Expression Profiling , Genetic Association Studies , Rabbits , Real-Time Polymerase Chain Reaction , Ventricular Dysfunction, Left/genetics
7.
PLoS One ; 6(10): e26481, 2011.
Article in English | MEDLINE | ID: mdl-22039496

ABSTRACT

The faster drugs of abuse reach the brain, the more addictive they can be. It is not known why this is. Environmental stimuli associated with drugs can promote the development and persistence of addiction by invigorating and precipitating drug-seeking behaviour. We determined, therefore, whether cues associated with the self-administration of rapidly delivered cocaine (injected intravenously over 5 versus 90 seconds) would acquire greater conditioned rewarding properties, as assessed by the performance of an operant response reinforced solely by the cues. Rats nose-poked for intravenous cocaine infusions delivered either over 5 or 90 seconds. Discrete visual cues accompanied each infusion. The rats could then press a lever to obtain the cues--now a conditioned reward--or an inactive lever. Rats in both the 5- and 90-second groups pressed more on the active versus inactive lever following extensive (24 sessions) but not following limited (3 sessions) self-administration training. There were no group differences in this behaviour. Following withdrawal from cocaine self-administration, lever discrimination progressively abated in both groups and was lost by withdrawal day 30. However, the rewarding properties of the cues were not "forgotten" because on withdrawal days 32-33, amphetamine selectively enhanced active-lever pressing, and did so to a similar extent in both groups. Thus, cues paired with rapid or slower cocaine delivery acquire similar conditioned rewarding properties. We conclude, therefore, that the rapid delivery of cocaine to the brain promotes addiction by mechanisms that might not involve a greater ability of drug cues to control behaviour.


Subject(s)
Cocaine/administration & dosage , Conditioning, Operant , Reward , Self Administration , Animals , Male , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...